Answers are grounded in this paper and cite their sources.
Liver transplantation (LT) normalizes fasting tolerance in glycogen storage disease type (GSD) 1b. However, reported outcomes post-LT with respect to correction of neutropenia, infection risk and growth are varied. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been recently shown to improve neutropenia in GSD1b patients.
No takes yet. Share an insight, caveat, or question.
Rajasekaran et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: